Innovation Pharmaceuticals (OTCMKTS:IPIX) Stock Gains Momentum: Here is Why

October 11, 2022

There were many stocks which got off to a flying start to the week on Monday and one of those was the Innovation Pharmaceuticals (OTCMKTS:IPIX) stock, which ended up with gains of 14%. The clinical stage biopharmaceutical company came into focus among investors on Monday in light of the announcement last week of the publication of a scientific article last week. Trading Data On Monday, IPIX stock increased 13.64% to…

Read More >>

Innovation Pharmaceuticals (OTCMKTS:IPIX) Stock In Focus After Recent News

September 29, 2022

In recent days, the Innovation Pharmaceuticals (OTCMKTS:IPIX) stock has come into significant focus among investors and it may be a good time to take a closer look into it. There was no news about the company yesterday but it had in fact been in the news earlier on in the month on September 15. Trading Data On Wednesday, IPIX stock surged 2.82% to $0.0399 with more than 141.35K shares, compared…

Read More >>

Innovation Pharmaceuticals (OTCMKTS:IPIX) Talks about Progress of BT BeaMedical in Advancement of New Surgical Laser Platform

September 14, 2022

Innovation Pharmaceuticals (OTCMKTS:IPIX) has provided an update for shareholders on September 13, 2022, regarding the current progress by BT BeaMedical Technologies Ltd., previously known as Squalus Medical Ltd. The company had talked about taking a keen interest in BT BeaMedical Technologies, back in June 2022. Trading Data On Tuesday, IPIX stock up 5.71% to $0.0370 with more than 196.03K shares, compared to its average volume of 904.20K shares. The stock…

Read More >>

Innovation Pharmaceuticals (OTCMKTS:IPIX) Stock Continues to Consolidate in a Range

September 6, 2022

There has not been a lot of news about Innovation Pharmaceuticals (OTCMKTS:IPIX) in recent days but it may just be the right time for investors to perhaps consider taking a closer look at the announcement from August 5. At the time the company made an announcement with regards to its defensing-mimetic medicine named Brilacidin which also demonstrated the ability to tackle a range of viruses. Trading Data On Friday, IPIX…

Read More >>